Neptune Technologies & Bioresources
The 10-second takeaway
For the quarter ended Aug. 31 (Q2), Neptune Technologies & Bioresources beat expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP loss per share grew.
Margins contracted across the board.
Neptune Technologies & Bioresources logged revenue of $8.2 million. The one analyst polled by S&P Capital IQ predicted revenue of $7.7 million on the same basis. GAAP reported sales were 84% higher than the prior-year quarter's $4.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.08. The one earnings estimate compiled by S&P Capital IQ forecast $0.01 per share. GAAP EPS were -$0.08 for Q2 compared to -$0.02 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 37.7%, 1,340 basis points worse than the prior-year quarter. Operating margin was -49.4%, 300 basis points worse than the prior-year quarter. Net margin was -48.1%, 2,340 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $8.4 million. On the bottom line, the average EPS estimate is $0.01.
Next year's average estimate for revenue is $29.9 million. The average EPS estimate is $0.02.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 29 members out of 174 rating the stock outperform, and 145 members rating it underperform. Among 97 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), three give Neptune Technologies & Bioresources a green thumbs-up, and 94 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Neptune Technologies & Bioresources is outperform, with an average price target of $8.28.
- Add Neptune Technologies & Bioresources to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.